OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Aducanumab: A new hope in Alzheimer's disease
Rouchan Ali, Ghanshyam Das Gupta, Pooja A. Chawla
Health Sciences Review (2022) Vol. 4, pp. 100039-100039
Closed Access | Times Cited: 19
Rouchan Ali, Ghanshyam Das Gupta, Pooja A. Chawla
Health Sciences Review (2022) Vol. 4, pp. 100039-100039
Closed Access | Times Cited: 19
Showing 19 citing articles:
Guidelines for pharmacotherapy in Alzheimer’s disease – A primer on FDA-approved drugs
Ashvin Varadharajan, Aarjith Damian Davis, Aishwarya Ghosh, et al.
Journal of Neurosciences in Rural Practice (2023) Vol. 14, pp. 566-573
Open Access | Times Cited: 33
Ashvin Varadharajan, Aarjith Damian Davis, Aishwarya Ghosh, et al.
Journal of Neurosciences in Rural Practice (2023) Vol. 14, pp. 566-573
Open Access | Times Cited: 33
Hypothalamic-Pituitary-Adrenal (HPA) Axis: Unveiling the Potential Mechanisms Involved in Stress-Induced Alzheimer’s Disease and Depression
Pratap Sharan, Chitra Vellapandian
Cureus (2024)
Open Access | Times Cited: 12
Pratap Sharan, Chitra Vellapandian
Cureus (2024)
Open Access | Times Cited: 12
A Review of the Common Neurodegenerative Disorders: Current Therapeutic Approaches and the Potential Role of Bioactive Peptides
Kuldeep Singh, Jeetendra Kumar Gupta, Shivendra Kumar, et al.
Current Protein and Peptide Science (2024) Vol. 25, Iss. 7, pp. 507-526
Closed Access | Times Cited: 5
Kuldeep Singh, Jeetendra Kumar Gupta, Shivendra Kumar, et al.
Current Protein and Peptide Science (2024) Vol. 25, Iss. 7, pp. 507-526
Closed Access | Times Cited: 5
An Expanded Narrative Review of Neurotransmitters on Alzheimer’s Disease: The Role of Therapeutic Interventions on Neurotransmission
Enes Akyüz, Alina Arulsamy, Feyza Şule Aslan, et al.
Molecular Neurobiology (2024)
Open Access | Times Cited: 5
Enes Akyüz, Alina Arulsamy, Feyza Şule Aslan, et al.
Molecular Neurobiology (2024)
Open Access | Times Cited: 5
Food and Drug Administration (FDA) Approvals of Biological Drugs in 2023
Alexander C. Martins, Mariana Y. Oshiro, Fernando Alberício, et al.
Biomedicines (2024) Vol. 12, Iss. 9, pp. 1992-1992
Open Access | Times Cited: 4
Alexander C. Martins, Mariana Y. Oshiro, Fernando Alberício, et al.
Biomedicines (2024) Vol. 12, Iss. 9, pp. 1992-1992
Open Access | Times Cited: 4
A Review of Clinical Biomarker Insights: Advances in Diagnosis and Prognosis of Early Alzheimer
Ramanathan Rajagopalan, S. Hariharan, N.R. Akshaya, et al.
Global Journal of Medical Pharmaceutical and Biomedical Update (2025) Vol. 20, pp. 5-5
Closed Access
Ramanathan Rajagopalan, S. Hariharan, N.R. Akshaya, et al.
Global Journal of Medical Pharmaceutical and Biomedical Update (2025) Vol. 20, pp. 5-5
Closed Access
A real-world safety surveillance study of aducanumab through the FDA adverse event reporting system
Jingjing Huang, Xiaohong Long, Chunyong Chen
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Jingjing Huang, Xiaohong Long, Chunyong Chen
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Modified Tacrine Derivatives as Multitarget-Directed Ligands for the Treatment of Alzheimer’s Disease: Synthesis, Biological Evaluation, and Molecular Modeling Study
Salma Fares, Walaa M. El Husseiny, Khalid B. Selim, et al.
ACS Omega (2023) Vol. 8, Iss. 29, pp. 26012-26034
Open Access | Times Cited: 9
Salma Fares, Walaa M. El Husseiny, Khalid B. Selim, et al.
ACS Omega (2023) Vol. 8, Iss. 29, pp. 26012-26034
Open Access | Times Cited: 9
Profiling aducanumab as a treatment option for alzheimer’s disease: an overview of efficacy, safety and tolerability
Shreeya Thussu, Aniketh Naidu, Sindhu Manivannan, et al.
Expert Review of Neurotherapeutics (2024), pp. 1-9
Closed Access | Times Cited: 3
Shreeya Thussu, Aniketh Naidu, Sindhu Manivannan, et al.
Expert Review of Neurotherapeutics (2024), pp. 1-9
Closed Access | Times Cited: 3
Advances in the Study of the Pathology and Treatment of Alzheimer’s Disease and Its Association with Periodontitis
Dan Tang, Chang Sun, Jumei Yang, et al.
Life (2023) Vol. 13, Iss. 11, pp. 2203-2203
Open Access | Times Cited: 6
Dan Tang, Chang Sun, Jumei Yang, et al.
Life (2023) Vol. 13, Iss. 11, pp. 2203-2203
Open Access | Times Cited: 6
The Overview of Drugs Used in Alzheimer’s Disease and Their Molecular Targets
Sukriti Vishwas, Monica Gulati, Molakpogu Ravindra Babu, et al.
(2023), pp. 351-376
Closed Access | Times Cited: 2
Sukriti Vishwas, Monica Gulati, Molakpogu Ravindra Babu, et al.
(2023), pp. 351-376
Closed Access | Times Cited: 2
Chelating Properties of N6O-Donors Toward Cu(II) Ions: Speciation in Aqueous Environments and Catalytic Activity of the Dinuclear Complexes
Andrea Cendron, Martina Chianese, Kamil Zarzycki, et al.
Molecules (2024) Vol. 29, Iss. 23, pp. 5708-5708
Open Access
Andrea Cendron, Martina Chianese, Kamil Zarzycki, et al.
Molecules (2024) Vol. 29, Iss. 23, pp. 5708-5708
Open Access
A new era in Alzheimer’s disease management: exploring aducanumab’s potential
Boyu Jiang
(2024), pp. 39-39
Closed Access
Boyu Jiang
(2024), pp. 39-39
Closed Access
Indole Alkaloids from Ochreinauclea Maingayi (Rubiaceae) as Butyrylcholinesterase Inhibitors and Their Paralysis Effect in Transgenic Caenorhabditis Elegans
Norfaizah Osman, Khalijah Awang, Hazrina Hazni, et al.
(2024)
Closed Access
Norfaizah Osman, Khalijah Awang, Hazrina Hazni, et al.
(2024)
Closed Access
Indole alkaloids from Ochreinauclea maingayi (Rubiaceae) as butyrylcholinesterase inhibitors and their paralysis effect in transgenic Caenorhabditis elegans
Norfaizah Osman, Khalijah Awang, Kooi Yeong Khaw, et al.
Natural Product Research (2024), pp. 1-8
Closed Access
Norfaizah Osman, Khalijah Awang, Kooi Yeong Khaw, et al.
Natural Product Research (2024), pp. 1-8
Closed Access
Role of novel drug delivery systems in managing Alzheimer's disease
Chahat, Abhimannu Shome, Pooja A. Chawla
Elsevier eBooks (2024), pp. 199-214
Closed Access
Chahat, Abhimannu Shome, Pooja A. Chawla
Elsevier eBooks (2024), pp. 199-214
Closed Access
Bridelia atroviridis (Phyllanthaceae) Aqueous Extract Attenuates Scopolamine-induced Amnesia and Depression in Rat: Role of Cholinergic, Monoaminergic, and Antioxidant Mechanisms
Mengue Ngadena Yolande Sandrine, Kavaye Kandeda Antoine, Bilanda Danielle Claude, et al.
Asian Journal of Research in Medical and Pharmaceutical Sciences (2023) Vol. 12, Iss. 3, pp. 82-100
Open Access
Mengue Ngadena Yolande Sandrine, Kavaye Kandeda Antoine, Bilanda Danielle Claude, et al.
Asian Journal of Research in Medical and Pharmaceutical Sciences (2023) Vol. 12, Iss. 3, pp. 82-100
Open Access
Comparative Study of Safety and Efficacy of Angiotensin-Receptor Blockers and Anti Amyloid-ß Monoclonal Antibodies for the Treatment of Alzheimer’s Disease: A Systematic Review
Kamran Shahid, Yonas Tamene, Shefali P. Mody, et al.
Cureus (2023)
Open Access
Kamran Shahid, Yonas Tamene, Shefali P. Mody, et al.
Cureus (2023)
Open Access
Monoclonal antibodies treatment for Alzheimer’s dementia – a literature review
Lavinia Horoșan, Diana-Elena Nistor, Stefan Zaharia
Romanian Journal of Psychiatry & Psychotherapy (2021) Vol. 23, Iss. 1
Open Access
Lavinia Horoșan, Diana-Elena Nistor, Stefan Zaharia
Romanian Journal of Psychiatry & Psychotherapy (2021) Vol. 23, Iss. 1
Open Access
